StockData
Biogen Inc. logo

Biogen Inc. (BIIB) stock

BIIBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 4/3056% above fair value
$250.79−0.86 (-0.34%)

Close on Nov 17, 2026Market cap $37.07BP/E 107.2Yield –

Biogen gross margin

Gross margin is gross profit as a percentage of revenue.

Biogen's gross margin for the twelve months ending Sep 30, 2026 was 74.0%. For fiscal 2025 it was 75.7%, against 76.1% the year before. The highest annual figure on record is 91.5% in fiscal 2010.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202575.7%−0.4
FY2024Dec 31, 202476.1%+1.9
FY2023Dec 31, 202374.2%−3.4
FY2022Dec 31, 202277.6%−3.2
FY2021Dec 31, 202180.8%−5.8
FY2020Dec 31, 202086.6%+0.2
FY2019Dec 31, 201986.4%−0.1
FY2018Dec 31, 201886.5%−0.2
FY2017Dec 31, 201786.7%−0.4
FY2016Dec 31, 201687.1%−1.4
FY2015Dec 31, 201588.5%+0.5
FY2014Dec 31, 201487.9%+0.3
FY2013Dec 31, 201387.6%−2.5
FY2012Dec 31, 201290.1%−0.6
FY2011Dec 31, 201190.8%−0.8
FY2010Dec 31, 201091.5%+0.2
FY2009Dec 31, 200991.3%+1.1
FY2008Dec 31, 200890.2%+0.8
FY2007Dec 31, 200789.4%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 202673.3%−0.1
Q2 FY2026Jun 30, 202671.6%−5.5
Q1 FY2026Mar 31, 202673.3%−0.8
Q4 FY2025Dec 31, 202578.3%+2.0
Q3 FY2025Sep 30, 202573.4%−0.7
Q2 FY2025Jun 30, 202577.1%−0.7
Q1 FY2025Mar 31, 202574.1%−2.2
Q4 FY2024Dec 31, 202476.2%+2.1
Q3 FY2024Sep 30, 202474.1%+0.2
Q2 FY2024Jun 30, 202477.8%+2.0
Q1 FY2024Mar 31, 202476.3%+3.2
Q4 FY2023Dec 31, 202374.1%−3.5
Q3 FY2023Sep 30, 202373.9%−7.4
Q2 FY2023Jun 30, 202375.9%−5.4
Q1 FY2023Mar 31, 202373.1%+2.9
Q4 FY2022Dec 31, 202277.6%+1.7
Q3 FY2022Sep 30, 202281.3%−0.3
Q2 FY2022Jun 30, 202281.3%−2.1
Q1 FY2022Mar 31, 202270.2%−12.0
Q4 FY2021Dec 31, 202175.9%−6.9
Q3 FY2021Sep 30, 202181.6%−5.1
Q2 FY2021Jun 30, 202183.4%−5.4
Q1 FY2021Mar 31, 202182.3%−4.9
Q4 FY2020Dec 31, 202082.8%−5.0
Q3 FY2020Sep 30, 202086.7%−1.4
Q2 FY2020Jun 30, 202088.8%+2.0
Q1 FY2020Mar 31, 202087.1%+4.4
Q4 FY2019Dec 31, 201987.8%+1.7
Q3 FY2019Sep 30, 201988.1%+1.5
Q2 FY2019Jun 30, 201986.8%−0.6
Q1 FY2019Mar 31, 201982.7%−3.0
Q4 FY2018Dec 31, 201886.1%+1.5
Q3 FY2018Sep 30, 201886.6%−1.4
Q2 FY2018Jun 30, 201887.5%−0.6
Q1 FY2018Mar 31, 201885.8%−0.6
Q4 FY2017Dec 31, 201784.6%−2.2
Q3 FY2017Sep 30, 201788.0%–
Q2 FY2017Jun 30, 201788.1%–
Q1 FY2017Mar 31, 201786.3%–
Q4 FY2016Dec 31, 201686.8%–

More Biogen figures

See a number that looks wrong?